Solara Active Pharma Sciences Limited — Others, 20-03-2025: Shareholders meeting

Solara Active Pharma Sciences Limited has announced a board meeting to seek shareholder approval through a postal ballot for appointing Mr. Sandeep Shashikantha Rao as the Managing Director and CEO for a three-year term starting February 21, 2025. His proposed remuneration comprises a fixed component of ₹3.25 crore per annum and a variable component of ₹75 lakh, aligned with industry standards.

This strategic appointment aims to leverage Mr. Sandeep's extensive experience in the pharmaceutical sector to enhance the company's operational efficiency and financial performance, which recently faced challenges. Investors may view this leadership change positively as a potential catalyst for growth amid earlier financial setbacks. Voting will begin on March 21, 2025, and conclude on April 19, 2025.